Latest News

Filters

Filter by tags: United States Europe Germany Clear all tag filters

72 news articles found


The International Energy Agency (IEA) in its latest report, Electricity 2024, dedicates a significant amount of space to nuclear power – a departure from its previous studies which treated it as peripheral. In its press release on the new report, IEA says the increase in electricity generation from renewables and nuclear "appears to be pushing the power sector's emissions into structural decline". Over the next three years, low-emissions generation is set to rise at twice the annual growth rate between 2018 and 2023. Global emissions from electricity generation are expected to decrease by 2.4% in 2024, followed by smaller declines in 2025 and 2026.

Date: Friday, 26 January 2024
Original article: neimagazine.com/news/newsiea-acknowledges-significance-of-nuclear-energy-in-new-report-11463539

UK-based nuclear technology company newcleo has announced a strategic and industrial partnership with France's NAAREA designed "to support all players in their industrial, technological, scientific and regulatory development" of Generation IV fast neutron reactors.

Date: Friday, 19 January 2024
Original article: neimagazine.com/news/newsnewcleo-and-naarea-partner-to-support-fast-reactor-development-11445892

Cameco has announced that its joint acquisition of Westinghouse Electric Company with Brookfield Asset Management, alongside its publicly listed affiliate Brookfield Renewable Partners and institutional partners, has now received all required regulatory approvals. The UK Competition and Markets Authority (CMA) has cleared the Cameco Corp and Brookfield Renewable Partners' $7.875bn deal to acquire Westinghouse Electric. CMA, which began considering the deal in August, said it will not refer the merger for further investigation.

Date: Thursday, 09 November 2023
Original article: neimagazine.com/news/newscameco-and-brookfield-receive-regulatory-approval-to-acquire-westinghouse-11282477

The USA's Colorado State University (CSU) and German laser fusion developer Marvel Fusion have established a public-private partnership to support construction of a $150m high-power laser and fusion research facility at Fort Collins on the CSU Foothills Campus. The facility is expected to become an international epicenter for research into inertial fusion energy, lasers and photonics, and high energy density physics under the partnership. CSU said that, pending finalisation of the financial details by the CSU System Board of Governors, the partnership will establish Fort Collins as a nexus for laser fusion research and deliver significant positive impacts to Colorado.

Date: Wednesday, 16 August 2023
Original article: neimagazine.com/news/newscolorado-state-university-and-marvel-fusion-to-build-laser-facility-11074743

France’s Framatome has announced a key advance in development of monolithic molybdenum-uranium (U-Mo) fuel for Germany’s Forschungsreaktor München II (FRM II) research reactor, operated by the Technical University of Munich (TUM).

Date: Wednesday, 03 May 2023
Original article: neimagazine.com/news/newsframatome-develops-high-density-fuel-for-germanys-frm-ii-research-reactor-10806850

The agreement by Canada, France, Japan, the UK and USA to leverage their civil nuclear power sectors to ensure a stable supply of nuclear fuel for existing and future reactors came as G7 climate, energy and environment ministers concluded a two-day meeting with a promise to accelerate the phase-out of fossil fuels.

Date: Tuesday, 18 April 2023
Original article: world-nuclear-news.org/Articles/Five-G7-countries-in-nuclear-fuel-agreement

Advances in emerging field of ‘theranostics’ are a game-changer Millions of patients around the globe rely on the regular and timely production of diagnostic and therapeutic isotopes produced in research reactors and accelerator facilities. Image courtesy IAEA. Advances in medical isotope diagnostics and therapy are holding promise for cancer patients, despite challenges facing the nuclear medical field in recent years related to radionuclide production and supply, rising costs, and stricter regulation.

Medical isotopes are radioactive substances used in various diagnostic and therapeutic procedures to treat various types of cancers and other conditions. They are essential for modern medicine, allowing physicians to visualise and target specific organs, tissues and cells in a patient’s body.

Over more than a decade, personalised medicine using nuclear techniques has been gaining pace, allowing doctors to tailor therapies and treatments to the specific needs and physiology of a patient, and to avoid harm to healthy organs or tissues.

According to Sven Van den Berghe, chief executive of Belgium-based isotope producer PanTera, one technique that has seen significant advances is known as theranostics – the term used to describe the combination of using one radioactive drug to diagnose and a second to deliver therapy to treat the main tumour and any metastatic tumours.

Date: Friday, 14 April 2023
Original article: nucnet.org/news/sector-aims-to-tackle-isotope-supply-problems-as-excitement-grows-over-targeted-therapies-4-4-2023